BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33088910)

  • 1. A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System.
    Nimer SD; Chapman J; Reidy L; Alencar A; Wu Y; Williams S; Pagan L; Gjolaj L; MacIntyre J; Triana M; Vance B; Andrews D; Fan YS; Zhou Y; Martinez O; Garcia-Buitrago M; Cray C; Tekin M; McCauley JL; Ruiz P; Pagan P; Lamar W; Alencar M; Bilbao D; Prieto S; Polania M; Suarez M; Lujardo M; Campos G; Morris M; Shukla B; Caban-Martinez A; Kobetz E; Parekh DJ; Jorda M
    Acad Pathol; 2020; 7():2374289520958200. PubMed ID: 33088910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.
    Zirbes J; Sterr CM; Steller M; Dapper L; Nonnenmacher-Winter C; Günther F
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):102. PubMed ID: 34215330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?
    Menting T; Krause K; Benz-Tettey F; Boehringer R; Laufer D; Gruber B; Crump M; Schieferdecker R; Reuhl S; Kaeferstein A; Engelhart S; Streeck H; Marx B; Aldabbagh S; Eis-Hübinger A; Rockstroh JK; Schwarze-Zander C
    Int J Hyg Environ Health; 2021 Jan; 231():113653. PubMed ID: 33137564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
    Campbell JR; Uppal A; Oxlade O; Fregonese F; Bastos ML; Lan Z; Law S; Oh CE; Russell WA; Sulis G; Winters N; Yanes-Lane M; Brisson M; Laszlo S; Evans TG; Menzies D
    CMAJ; 2020 Oct; 192(40):E1146-E1155. PubMed ID: 32907820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile SARS‑CoV‑2 screening facilities for rapid deployment and university-based diagnostic laboratory.
    Stanislawski N; Lange F; Fahnemann C; Riggers C; Wahalla MN; Porr M; Cholewa F; Jonczyk R; Thoms S; Witt M; Stahl F; Beutel S; Winkel A; Pott PC; Stiesch M; Paulsen M; Melk A; Lucas H; Heiden S; Blume H; Blume C
    Eng Life Sci; 2023 Feb; 23(2):2200026. PubMed ID: 36751470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020.
    Denny TN; Andrews L; Bonsignori M; Cavanaugh K; Datto MB; Deckard A; DeMarco CT; DeNaeyer N; Epling CA; Gurley T; Haase SB; Hallberg C; Harer J; Kneifel CL; Lee MJ; Louzao R; Moody MA; Moore Z; Polage CR; Puglin J; Spotts PH; Vaughn JA; Wolfe CR
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(46):1743-1747. PubMed ID: 33211678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-Based Testing Sites for SARS-CoV-2 - United States, March 2020-November 2021.
    Miller MF; Shi M; Motsinger-Reif A; Weinberg CR; Miller JD; Nichols E
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1706-1711. PubMed ID: 34882655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities - Detroit, Michigan, March-May 2020.
    Sanchez GV; Biedron C; Fink LR; Hatfield KM; Polistico JMF; Meyer MP; Noe RS; Copen CE; Lyons AK; Gonzalez G; Kiama K; Lebednick M; Czander BK; Agbonze A; Surma AR; Sandhu A; Mika VH; Prentiss T; Zervos J; Dalal DA; Vasquez AM; Reddy SC; Jernigan J; Kilgore PE; Zervos MJ; Chopra T; Bezold CP; Rehman NK
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(27):882-886. PubMed ID: 32644985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Psychological Experience of Obstetric Patients and Health Care Workers after Implementation of Universal SARS-CoV-2 Testing.
    Bender WR; Srinivas S; Coutifaris P; Acker A; Hirshberg A
    Am J Perinatol; 2020 Oct; 37(12):1271-1279. PubMed ID: 32757185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020.
    Taylor J; Carter RJ; Lehnertz N; Kazazian L; Sullivan M; Wang X; Garfin J; Diekman S; Plumb M; Bennet ME; Hale T; Vallabhaneni S; Namugenyi S; Carpenter D; Turner-Harper D; Booth M; Coursey EJ; Martin K; McMahon M; Beaudoin A; Lifson A; Holzbauer S; Reddy SC; Jernigan JA; Lynfield R;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(37):1288-1295. PubMed ID: 32966272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis for the novel coronavirus SARS-CoV-2: lessons learnt from the Ghana experience.
    Asante IA; Adusei-Poku M; Bonney HK; Bonney EY; Odoom JK; Obodai E; Aboagye J; Kotey EN; Nyarko S; Boatemaa L; Magnusen V; Lamptey H; Kyei GB; Ampofo WK
    Ghana Med J; 2020 Dec; 54(4 Suppl):77-85. PubMed ID: 33976445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a COVID-19 Control Plan on an Urban University Campus During a Second Wave of the Pandemic.
    Hamer DH; White LF; Jenkins HE; Gill CJ; Landsberg HE; Klapperich C; Bulekova K; Platt J; Decarie L; Gilmore W; Pilkington M; MacDowell TL; Faria MA; Densmore D; Landaverde L; Li W; Rose T; Burgay SP; Miller C; Doucette-Stamm L; Lockard K; Elmore K; Schroeder T; Zaia AM; Kolaczyk ED; Waters G; Brown RA
    JAMA Netw Open; 2021 Jun; 4(6):e2116425. PubMed ID: 34170303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center.
    Weemaes M; Martens S; Cuypers L; Van Elslande J; Hoet K; Welkenhuysen J; Goossens R; Wouters S; Houben E; Jeuris K; Laenen L; Bruyninckx K; Beuselinck K; André E; Depypere M; Desmet S; Lagrou K; Van Ranst M; Verdonck AKLC; Goveia J
    J Am Med Inform Assoc; 2020 Aug; 27(8):1293-1299. PubMed ID: 32348469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.
    Long DR; Gombar S; Hogan CA; Greninger AL; OReilly Shah V; Bryson-Cahn C; Stevens B; Rustagi A; Jerome KR; Kong CS; Zehnder J; Shah NH; Weiss NS; Pinsky BA; Sunshine J
    medRxiv; 2020 May; ():. PubMed ID: 32511542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Sectional Prevalence of SARS-CoV-2 Among Skilled Nursing Facility Employees and Residents Across Facilities in Seattle.
    Weil AA; Newman KL; Ong TD; Davidson GH; Logue J; Brandstetter E; Magedson A; McDonald D; McCulloch DJ; Neme S; Lewis J; Duchin JS; Zhong W; Starita LM; Bedford T; Roxby AC; Chu HY
    J Gen Intern Med; 2020 Nov; 35(11):3302-3307. PubMed ID: 32875494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years - Mississippi, September-November 2020.
    Hobbs CV; Martin LM; Kim SS; Kirmse BM; Haynie L; McGraw S; Byers P; Taylor KG; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1925-1929. PubMed ID: 33332298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.